Teva (TEVA) Launches Generic Version of EXJADE Tablets For Oral Suspension in U.S.
Tweet Send to a Friend
Teva Pharmaceutical Industries Ltd., (NYSE: TEVA) today announced the launch of a generic version of EXJADE®1 (deferasirox) Tablets for Oral ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE